BANDIERA, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 2.575
EU - Europa 1.142
AS - Asia 861
SA - Sud America 110
Continente sconosciuto - Info sul continente non disponibili 76
AF - Africa 21
OC - Oceania 3
Totale 4.788
Nazione #
US - Stati Uniti d'America 2.510
PL - Polonia 457
CN - Cina 330
SG - Singapore 239
UA - Ucraina 162
DE - Germania 133
HK - Hong Kong 96
IT - Italia 95
BR - Brasile 93
FI - Finlandia 88
VN - Vietnam 69
GB - Regno Unito 62
FR - Francia 39
CA - Canada 35
IN - India 28
TR - Turchia 26
IE - Irlanda 25
RU - Federazione Russa 20
SE - Svezia 18
BD - Bangladesh 15
IQ - Iraq 10
ES - Italia 8
MX - Messico 8
NL - Olanda 8
ZA - Sudafrica 8
AR - Argentina 7
ID - Indonesia 7
LT - Lituania 7
TW - Taiwan 6
BE - Belgio 5
CL - Cile 4
CZ - Repubblica Ceca 4
HN - Honduras 4
JP - Giappone 4
KR - Corea 4
MA - Marocco 4
NG - Nigeria 4
CR - Costa Rica 3
EU - Europa 3
GT - Guatemala 3
KG - Kirghizistan 3
PK - Pakistan 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
EC - Ecuador 2
GP - Guadalupe 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MY - Malesia 2
NP - Nepal 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LY - Libia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.716
Città #
Warsaw 456
Fairfield 269
Ashburn 233
Woodbridge 226
Seattle 153
Houston 139
Singapore 135
San Jose 129
Jacksonville 107
Ann Arbor 94
Wilmington 90
Dearborn 88
Cambridge 84
Hong Kong 78
Chandler 77
New York 70
Helsinki 58
Los Angeles 54
Beijing 53
Council Bluffs 47
Princeton 44
The Dalles 41
Nanjing 35
Shanghai 26
Dublin 25
Munich 25
Istanbul 22
Jinan 20
Chicago 18
Columbus 18
Lauterbourg 18
Santa Clara 18
Dong Ket 16
Kunming 16
San Francisco 16
Hanoi 15
London 15
Dallas 14
Des Moines 14
Nanchang 14
Shenyang 14
Central 13
Ho Chi Minh City 13
Toronto 13
Milan 12
São Paulo 12
Changsha 11
San Diego 11
Turku 11
Buffalo 10
Jiaxing 10
Brescia 9
Hebei 9
Phoenix 9
Monmouth Junction 8
Tianjin 8
Montreal 7
Moscow 7
Orem 7
Stockholm 7
Zhengzhou 7
Hangzhou 6
Manchester 6
Redondo Beach 6
Brussels 5
Chennai 5
Guangzhou 5
Jakarta 5
Kyiv 5
Lancaster 5
Mexico City 5
Miami 5
Mumbai 5
New Delhi 5
Ningbo 5
North Bergen 5
Abuja 4
Baghdad 4
Belo Horizonte 4
Campinas 4
Denver 4
Falkenstein 4
Hefei 4
Johannesburg 4
Las Vegas 4
Leawood 4
Norwalk 4
Osasco 4
Poplar 4
Rio de Janeiro 4
Rome 4
Atlanta 3
Bishkek 3
Boston 3
Cape Town 3
Casablanca 3
Da Nang 3
Guatemala City 3
Lanzhou 3
North 3
Totale 3.443
Nome #
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 375
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 374
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 344
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 303
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 227
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 211
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 210
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 209
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 200
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 195
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 188
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 186
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 185
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 183
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 178
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 178
Mammaglobin B expression in human endometrial cancer 176
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 168
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 159
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 156
Claudin-7 expression in human epithelial ovarian cancer 155
Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer 153
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study 75
Totale 4.788
Categoria #
all - tutte 19.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022170 0 0 0 3 1 14 20 16 6 46 22 42
2022/2023228 45 10 12 7 19 41 1 26 37 2 12 16
2023/2024355 17 9 32 32 24 88 18 27 50 24 7 27
2024/2025431 4 14 5 56 39 55 27 19 39 20 102 51
2025/20261.022 113 105 56 154 141 92 161 28 48 93 25 6
2026/2027219 30 32 44 113 0 0 0 0 0 0 0 0
Totale 4.788